ASCO Plenary Apr 2023 - ASCO Plenary Series: April 2023
Apr 20 - Apr 20, 2023 | AlexandriaVAUS
LARVOL is not affiliated with ASCO Plenary Series: April 2023 and all trademarks, logos, and brand names are property of their respective owners
Condition
Product
MOA
Trial Name/ID
Showing 2 titles linked to Trials
Perioperative toripalimab + platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): Interim event-free survival (EFS) analysis of the phase III Neotorch study.
Discussion
ASCO Plenary SeriesKRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced solid tumors harboring a KRASG12C mutation.